From a bank CFO seat, the single most important factor is recovery certainty relative to time. Rates change the math fast. Holding a non performing loan only works when there is clear line of sight on timing, quantum, and control of recovery. Cash today carries a premium in a high rate environment. A recovery that looks attractive two years out weakens once you discount it properly and layer in execution risk. I always come back to one core question. Do we control the outcome or are we waiting on courts, restructurings, or borrower behavior? If recovery depends on timelines outside our control, value erodes every quarter. Carry costs add up. Capital stays locked. Management attention gets pulled into a file that refuses to move. On paper, the recovery percentage still looks decent. In reality, the asset keeps aging. Selling becomes the smarter call when uncertainty stretches. Even at a haircut, converting a stuck loan into liquidity restores flexibility. That capital can move into assets with cleaner risk and stronger yield in the current rate cycle. Holding makes sense only when recovery is near term, legally tight, and operationally contained. Timing matters more than theoretical upside. In this environment, certainty beats optimism. Liquidity with control outperforms delayed hope.
Being the founder and managing consultant at spectup, what I consistently hear from bank CFOs is that the single most important factor in deciding whether to hold or sell non performing loans right now is recovery certainty, not headline yield. In today's rate environment, optionality matters less than clarity. I remember advising on a situation where holding the loan looked attractive on paper because rates were rising, but the underlying borrower viability was quietly deteriorating. The CFO ultimately focused on the probability and timing of cash recovery rather than theoretical upside. That decision preserved capital and reduced management distraction. What has changed in this environment is that time has become more expensive. Carrying non performing assets ties up balance sheet capacity, capital allocation, and senior attention. CFOs I work with increasingly ask whether internal teams can realistically manage workouts efficiently or whether value is being eroded month by month. One executive put it plainly, if recovery requires perfect execution, it is probably not a hold. That mindset reflects discipline more than pessimism. Another element is regulatory and reporting pressure. Holding non performing loans longer invites scrutiny and limits strategic flexibility, especially when growth opportunities exist elsewhere. I have seen CFOs choose to sell at a discount simply to redeploy capital into clearer, lower friction returns. At spectup, we often compare this to portfolio management in venture, sometimes cutting a position early protects the rest of the portfolio. The strongest decisions come from separating sunk cost emotion from forward looking reality. When CFOs anchor decisions on realistic recovery paths, internal capability, and opportunity cost, the choice becomes clearer. In my experience, selling is not a sign of weakness, it is often a sign of disciplined capital stewardship in uncertain rate cycles.
For me, the single most important factor is the risk-adjusted recovery potential of the non-performing loan. In today's rate environment, higher interest rates can improve yields on performing assets, so holding a non-performing loan only makes sense if the expected recovery—after considering costs of collection, potential collateral liquidation, and timing—exceeds what we could earn elsewhere. If the outlook is uncertain or the recovery timeline is long, selling at a discount can free up capital for higher-yield, lower-risk opportunities. Essentially, it's about comparing the realistic net value of holding versus the opportunity cost of redeploying that capital, rather than just focusing on the nominal loan balance.